The Novel Cannabinoid CB1 Receptor Neutral Antagonist AM4113 Suppresses Food Intake and Food-Reinforced Behavior but Does not Induce Signs of Nausea in Rats

Effects of the cannabinoid CB1-receptor neutral antagonist AM4113 and antagonist/inverse agonist rimonabant on fentanyl discrimination in male rats - ScienceDirect

Neutral antagonism at the cannabinoid 1 receptor: a safer

Frontiers Peripheral CB1 Receptor Neutral Antagonist, AM6545, Ameliorates Hypometabolic Obesity and Improves Adipokine Secretion in Monosodium Glutamate Induced Obese Mice

The novel cannabinoid CB1 antagonist AM6545 suppresses food intake and food-reinforced behavior - ScienceDirect

DDC, Free Full-Text

Medicina, Free Full-Text

Molecules, Free Full-Text

The endocannabinoid system – current implications for drug development - Fowler - 2021 - Journal of Internal Medicine - Wiley Online Library

Anti‐obesity efficacy of LH‐21, a cannabinoid CB1 receptor

The Novel Cannabinoid CB1 Receptor Neutral Antagonist AM4113 Suppresses Food Intake and Food-Reinforced Behavior but Does not Induce Signs of Nausea in Rats

Molecules, Free Full-Text

Overcoming the Psychiatric Side Effects of the Cannabinoid CB1 Receptor Antagonists: Current Approaches for Therapeutics Development

Evaluation of the potential of the phytocannabinoids

Full article: A comprehensive patents review on cannabinoid 1

Inverse agonism of cannabinoid CB1 receptors potentiates LiCl‐induced nausea in the conditioned gaping model in rats - Limebeer - 2010 - British Journal of Pharmacology - Wiley Online Library